Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Head and Neck Cancer

Targeted Therapy and Nasopharyngeal Cancer

01/06/2009

Question:

Would targeted therapy (Cetuximab) be a consideration for an elderly person with stage IV nasophyarngeal cancer?

Answer:

Cetuximab may be included in the treatment plan in patients who are elderly or who have poor performance status, either alone or in combination with other agents.

For more information:

Go to the Head and Neck Cancer health topic, where you can:

Response by:

Panayiotis  Savvides, MD Panayiotis Savvides, MD
Assistant Professor of Medicine
School of Medicine
Case Western Reserve University

Heather  Hines, RN Heather Hines, RN
Medical Oncology Nurse
School of Medicine
Case Western Reserve University